Xiangyu Capital Expenditures from 2010 to 2024

688626 Stock   33.33  1.64  5.18%   
Xiangyu Medical's Capital Expenditures is increasing over the years with slightly volatile fluctuation. Overall, Capital Expenditures is expected to go to about 503.2 M this year. From 2010 to 2024 Xiangyu Medical Capital Expenditures quarterly data regression line had arithmetic mean of  111,322,752 and r-squared of  0.58. View All Fundamentals
 
Capital Expenditures  
First Reported
2010-12-31
Previous Quarter
479.3 M
Current Value
503.2 M
Quarterly Volatility
164.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Xiangyu Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xiangyu Medical's main balance sheet or income statement drivers, such as Tax Provision of 15 M, Net Interest Income of 21.5 M or Interest Income of 20.2 M, as well as many indicators such as . Xiangyu financial statements analysis is a perfect complement when working with Xiangyu Medical Valuation or Volatility modules.
  
This module can also supplement various Xiangyu Medical Technical models . Check out the analysis of Xiangyu Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Xiangyu Stock

Xiangyu Medical financial ratios help investors to determine whether Xiangyu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xiangyu with respect to the benefits of owning Xiangyu Medical security.